CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
CEL SCI CORP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.65−0.14 (-7.82%)
Close on Oct 19, 2026
- Market cap
- $19.99M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Cel Sci has not reported a dividend
No dividend per share appears in Cel Sci's annual filings since fiscal 2010.